RBM46 Inhibitors
RBM46 inhibitors belong to a specialized class of chemical compounds designed to interact with and inhibit the activity of the RNA-binding protein 46 (RBM46). RBM46 is part of a broader family of RNA-binding proteins, which play critical roles in the post-transcriptional regulation of gene expression, including processes such as RNA splicing, transport, localization, and stability. The exact biological function of RBM46 remains an area of ongoing research, but it is understood that the precise modulation of RBM46 activity is crucial for the maintenance of normal cellular functions. Inhibitors targeting RBM46 are typically small molecules that have been crafted to bind with high affinity and specificity to the protein, thus modulating its interaction with RNA molecules and consequently its activity within the cell.
The development of RBM46 inhibitors necessitates a deep understanding of the structure and function of the protein itself. RBM46 contains domains that are characteristic of RNA-binding proteins, including RNA recognition motifs (RRMs) that facilitate its interaction with specific RNA sequences. Inhibitors of RBM46 are designed to disrupt these protein-RNA interactions without affecting the function of other RNA-binding proteins, ensuring selectivity and minimizing off-target effects. The discovery and optimization of these inhibitors often involve a combination of computational modeling to predict how potential compounds will interact with the protein's structure, and empirical methods such as high-throughput screening to identify promising candidates. The structural features of RBM46 inhibitors can vary widely, but they generally possess functional groups that enable them to engage in hydrogen bonding, electrostatic, and hydrophobic interactions with the target protein, thereby obstructing its normal function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and prevents their depolymerization, disrupting the mitotic spindle function and arresting cell division. This may indirectly lead to the inhibition of RBM46 by preventing cellular division and hence affecting the turnover or the amount of RBM46 produced as cells are unable to proceed through the cell cycle. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a potent inhibitor of the PI3K/Akt pathway. By inhibiting this pathway, it can lead to decreased cell survival and proliferation. Since RBM46 is involved in RNA binding and may play a role in cell cycle regulation, the inhibition of PI3K/Akt pathway can indirectly reduce RBM46 activity by impacting the survival of cells expressing this protein. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK, which subsequently inhibits the MAPK/ERK pathway. The MAPK/ERK pathway is involved in cell cycle progression and growth signals. Inhibition of this pathway could indirectly decrease RBM46 functional activity by limiting cell proliferation and growth signals that may upregulate RBM46. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is a central regulator of cell growth and proliferation. Through mTOR inhibition, the synthesis of proteins involved in cell cycle progression is decreased, which could lead to a reduction in RBM46 levels or activity indirectly by slowing down cell growth and division. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor, affecting chromatin structure and gene expression. By altering gene expression profiles, it may indirectly influence RBM46 activity by modifying the transcription of genes involved in RBM46 pathways or its regulatory mechanisms. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor that can lead to increased levels of ubiquitinated proteins and cell cycle arrest. This could result in decreased RBM46 activity due to the accumulation of regulatory proteins that might inhibit RBM46 function or due to the general inhibition of cell cycle progression. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Nutlin-3 disrupts the interaction between p53 and MDM2, leading to stabilization and activation of p53. p53 activation can lead to cell cycle arrest or apoptosis. The alteration in cell cycle dynamics could indirectly inhibit RBM46 activity by affecting the regulatory networks in which RBM46 is involved. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, leading to an increase in cytosolic calcium levels and initiating endoplasmic reticulum stress. This stress response can lead to cell cycle arrest, potentially affecting RBM46 activity indirectly by impacting the cell's regulatory environment. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of MEK, which acts upstream of the MAPK/ERK pathway. By inhibiting this pathway, PD98059 can reduce cell proliferation and growth, potentially leading to decreased RBM46 activity by indirectly affecting the cellular environment that regulates RBM46 function. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis by interfering with the translocation step in protein elongation. This can lead to a reduction in RBM46 protein levels indirectly as it affects the general protein synthesis machinery of the cell. | ||||||